Kyriakides Z S, Kremastinos D T, Bofilis E, Tousoulis D, Antoniadis A, Webb D J
2nd Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece.
Heart. 2000 Aug;84(2):176-82. doi: 10.1136/heart.84.2.176.
To examine the contribution of endothelin type A (ET(A)) receptor stimulation by endogenously generated endothelin-1 (ET-1) to the maintenance of coronary vascular tone in humans.
Controlled clinical study.
Tertiary cardiovascular referral centre.
14 subjects were studied, seven with normal coronary arteries and seven with coronary artery disease, mean (SEM) age, 53 (2) years.
After diagnostic coronary arteriography, BQ-123 (a selective ET(A) receptor antagonist; 100 nmol/min) in 0.9% saline, was infused into the left coronary artery at a rate of 1 ml/min for 60 minutes. Eight control subjects received saline alone.
Blood flow velocity in the left anterior descending coronary artery, measured using a Doppler flow guidewire; coronary arteriography performed at baseline and immediately at the end of the BQ-123 or saline infusion to measure the diameter of proximal and distal left anterior descending coronary artery segments.
The diameter of the proximal segment increased by 6 (2)%, while that of the distal segment increased by 12 (3)% after BQ-123 (both p < 0.05 v baseline). Coronary blood flow increased from 75 (10) to 92 (10) ml/min and coronary vascular resistance decreased from 1.99 (0.36) to 1.44 (0. 22) mm Hg/ml/min after BQ-123 (both p < 0.05 v baseline). The response to BQ-123 of patients with and without coronary artery disease was similar. There was no effect of saline in the controls.
Endogenously produced ET-1 contributes to the maintenance of basal coronary artery tone in humans by ET(A) receptor stimulation. The role of ET(B) receptors remains to be defined.
研究内源性生成的内皮素 -1(ET-1)刺激A型内皮素(ET(A))受体对维持人体冠状动脉血管张力的作用。
对照临床研究。
三级心血管转诊中心。
研究了14名受试者,7名冠状动脉正常,7名患有冠状动脉疾病,平均(标准误)年龄为53(2)岁。
在诊断性冠状动脉造影后,将溶于0.9%生理盐水的BQ-123(一种选择性ET(A)受体拮抗剂;100 nmol/分钟)以1毫升/分钟的速度注入左冠状动脉,持续60分钟。8名对照受试者仅接受生理盐水。
使用多普勒血流导丝测量左前降支冠状动脉的血流速度;在基线时以及BQ-123或生理盐水输注结束后立即进行冠状动脉造影,以测量左前降支冠状动脉近端和远端节段的直径。
BQ-123注射后,近端节段直径增加了6(2)%,而远端节段直径增加了12(3)%(两者与基线相比p均<0.05)。BQ-123注射后,冠状动脉血流量从75(10)增加到92(10)毫升/分钟,冠状动脉血管阻力从1.99(0.36)降至1.44(0.22)毫米汞柱/毫升/分钟(两者与基线相比p均<0.05)。有和没有冠状动脉疾病的患者对BQ-123的反应相似。对照组中生理盐水无作用。
内源性产生的ET-1通过刺激ET(A)受体有助于维持人体冠状动脉的基础张力。ET(B)受体的作用仍有待确定。